Logo image of SNYR

SYNERGY CHC CORP (SNYR) Stock Fundamental Analysis

NASDAQ:SNYR - US87165D2080 - Common Stock

2.32 USD
-0.02 (-0.85%)
Last: 9/5/2025, 8:00:02 PM
2.4 USD
+0.08 (+3.45%)
After Hours: 9/5/2025, 8:00:02 PM
Fundamental Rating

4

Taking everything into account, SNYR scores 4 out of 10 in our fundamental rating. SNYR was compared to 36 industry peers in the Personal Care Products industry. While SNYR is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on SNYR.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

SNYR had positive earnings in the past year.
In multiple years SNYR reported negative net income over the last 5 years.
In multiple years SNYR reported negative operating cash flow during the last 5 years.
SNYR Yearly Net Income VS EBIT VS OCF VS FCFSNYR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 5M -5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 13.57%, SNYR belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
SNYR has a better Return On Invested Capital (37.12%) than 97.22% of its industry peers.
Industry RankSector Rank
ROA 13.57%
ROE N/A
ROIC 37.12%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNYR Yearly ROA, ROE, ROICSNYR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

SNYR's Profit Margin of 6.10% is fine compared to the rest of the industry. SNYR outperforms 69.44% of its industry peers.
The Operating Margin of SNYR (16.65%) is better than 86.11% of its industry peers.
In the last couple of years the Operating Margin of SNYR has grown nicely.
Looking at the Gross Margin, with a value of 67.87%, SNYR is in line with its industry, outperforming 58.33% of the companies in the same industry.
In the last couple of years the Gross Margin of SNYR has remained more or less at the same level.
Industry RankSector Rank
OM 16.65%
PM (TTM) 6.1%
GM 67.87%
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
SNYR Yearly Profit, Operating, Gross MarginsSNYR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

SNYR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SNYR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SNYR has more shares outstanding
SNYR has a better debt/assets ratio than last year.
SNYR Yearly Shares OutstandingSNYR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2023 2024 20M 40M 60M 80M
SNYR Yearly Total Debt VS Total AssetsSNYR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.65, we must say that SNYR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.65, SNYR is doing worse than 69.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.65
ROIC/WACC3.68
WACC10.08%
SNYR Yearly LT Debt VS Equity VS FCFSNYR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

SNYR has a Current Ratio of 1.91. This is a normal value and indicates that SNYR is financially healthy and should not expect problems in meeting its short term obligations.
SNYR has a Current ratio of 1.91. This is comparable to the rest of the industry: SNYR outperforms 52.78% of its industry peers.
SNYR has a Quick Ratio of 1.62. This is a normal value and indicates that SNYR is financially healthy and should not expect problems in meeting its short term obligations.
SNYR's Quick ratio of 1.62 is fine compared to the rest of the industry. SNYR outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.62
SNYR Yearly Current Assets VS Current LiabilitesSNYR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

SNYR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.60%.
Looking at the last year, SNYR shows a very negative growth in Revenue. The Revenue has decreased by -18.57% in the last year.
SNYR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.48% yearly.
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%N/A

3.2 Future

SNYR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.50% yearly.
SNYR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.94% yearly.
EPS Next Y13.89%
EPS Next 2Y11.8%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue Next Year23.04%
Revenue Next 2Y25.98%
Revenue Next 3Y20.94%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNYR Yearly Revenue VS EstimatesSNYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2023 2024 2025 2026 2027 20M 40M 60M
SNYR Yearly EPS VS EstimatesSNYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.29, the valuation of SNYR can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of SNYR indicates a rather cheap valuation: SNYR is cheaper than 97.22% of the companies listed in the same industry.
SNYR is valuated cheaply when we compare the Price/Earnings ratio to 27.06, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.05, the valuation of SNYR can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SNYR indicates a rather cheap valuation: SNYR is cheaper than 97.22% of the companies listed in the same industry.
SNYR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.69.
Industry RankSector Rank
PE 8.29
Fwd PE 5.05
SNYR Price Earnings VS Forward Price EarningsSNYR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNYR is valued a bit cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.31
SNYR Per share dataSNYR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SNYR's earnings are expected to grow with 41.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y11.8%
EPS Next 3Y41.5%

0

5. Dividend

5.1 Amount

SNYR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SYNERGY CHC CORP

NASDAQ:SNYR (9/5/2025, 8:00:02 PM)

After market: 2.4 +0.08 (+3.45%)

2.32

-0.02 (-0.85%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)12-04 2025-12-04
Inst Owners11.2%
Inst Owner ChangeN/A
Ins Owners8.7%
Ins Owner Change0.02%
Market Cap25.96M
Analysts82.86
Price Target10.2 (339.66%)
Short Float %0.82%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.07%
Min EPS beat(2)-90.2%
Max EPS beat(2)40.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.9%
Min Revenue beat(2)-11.25%
Max Revenue beat(2)-4.54%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-14.58%
EPS NY rev (3m)-31.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-8.22%
Revenue NY rev (3m)2843.49%
Valuation
Industry RankSector Rank
PE 8.29
Fwd PE 5.05
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 8.31
EPS(TTM)0.28
EY12.07%
EPS(NY)0.46
Fwd EY19.78%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.11
BVpS-1.4
TBVpS-1.42
PEG (NY)0.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.57%
ROE N/A
ROCE 76.43%
ROIC 37.12%
ROICexc 37.71%
ROICexgc 38.5%
OM 16.65%
PM (TTM) 6.1%
GM 67.87%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
F-ScoreN/A
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.72
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.62
Altman-Z 0.65
F-ScoreN/A
WACC10.08%
ROIC/WACC3.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y13.89%
EPS Next 2Y11.8%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%N/A
Revenue Next Year23.04%
Revenue Next 2Y25.98%
Revenue Next 3Y20.94%
Revenue Next 5YN/A
EBIT growth 1Y-46.32%
EBIT growth 3YN/A
EBIT growth 5Y26.96%
EBIT Next Year68.78%
EBIT Next 3Y35.04%
EBIT Next 5YN/A
FCF growth 1Y-1239.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1239.06%
OCF growth 3YN/A
OCF growth 5YN/A